UTI Statistics
Total Valuation
UTI has a market cap or net worth of $807.05 million. The enterprise value is $999.41 million.
| Market Cap | 807.05M |
| Enterprise Value | 999.41M |
Important Dates
The next confirmed earnings date is Wednesday, May 8, 2024, after market close.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
UTI has 53.73 million shares outstanding. The number of shares has increased by 8.81% in one year.
| Shares Outstanding | 53.73M |
| Shares Change (YoY) | +8.81% |
| Shares Change (QoQ) | +7.86% |
| Owned by Insiders (%) | 2.71% |
| Owned by Institutions (%) | 72.78% |
| Float | 42.89M |
Valuation Ratios
The trailing PE ratio is 57.46 and the forward PE ratio is 20.13. UTI's PEG ratio is 1.75.
| PE Ratio | 57.46 |
| Forward PE | 20.13 |
| PS Ratio | 1.21 |
| Forward PS | 1.10 |
| PB Ratio | 3.60 |
| P/FCF Ratio | 233.87 |
| PEG Ratio | 1.75 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.42, with an EV/FCF ratio of 292.14.
| EV / Earnings | 105.67 |
| EV / Sales | 1.51 |
| EV / EBITDA | 11.42 |
| EV / EBIT | 25.91 |
| EV / FCF | 292.14 |
Financial Position
The company has a current ratio of 1.09, with a Debt / Equity ratio of 1.57.
| Current Ratio | 1.09 |
| Quick Ratio | 0.98 |
| Debt / Equity | 1.57 |
| Debt / EBITDA | 3.98 |
| Debt / FCF | 101.77 |
| Interest Coverage | 3.47 |
Financial Efficiency
Return on equity (ROE) is 4.30% and return on invested capital (ROIC) is 3.99%.
| Return on Equity (ROE) | 4.30% |
| Return on Assets (ROA) | 1.30% |
| Return on Capital (ROIC) | 3.99% |
| Revenue Per Employee | $220,700 |
| Profits Per Employee | $3,153 |
| Employee Count | 3,000 |
| Asset Turnover | 0.92 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, UTI has paid $7.40 million in taxes.
| Income Tax | 7.40M |
| Effective Tax Rate | 43.90% |
Stock Price Statistics
The stock price has increased by +113.94% in the last 52 weeks. The beta is 1.21, so UTI's price volatility has been higher than the market average.
| Beta (1Y) | 1.21 |
| 52-Week Price Change | +113.94% |
| 50-Day Moving Average | 14.90 |
| 200-Day Moving Average | 11.28 |
| Relative Strength Index (RSI) | 52.13 |
| Average Volume (30 Days) | 640,167 |
Short Selling Information
The latest short interest is 1.47 million, so 2.74% of the outstanding shares have been sold short.
| Short Interest | 1.47M |
| Short Previous Month | 1.24M |
| Short % of Shares Out | 2.74% |
| Short % of Float | 3.43% |
| Short Ratio (days to cover) | 2.69 |
Income Statement
In the last 12 months, UTI had revenue of $662.10 million and earned $9.46 million in profits. Earnings per share was $0.26.
| Revenue | 662.10M |
| Gross Profit | 301.23M |
| Operating Income | 31.18M |
| Pretax Income | 27.46M |
| Net Income | 9.46M |
| EBITDA | 87.53M |
| EBIT | 38.57M |
| Earnings Per Share (EPS) | $0.26 |
Balance Sheet
The company has $148.82 million in cash and $348.17 million in debt, giving a net cash position of -$199.35 million or -$3.71 per share.
| Cash & Cash Equivalents | 148.82M |
| Total Debt | 348.17M |
| Net Cash | -199.35M |
| Net Cash Per Share | -$3.71 |
| Equity / Book Value | 222.19M |
| Book Value Per Share | 4.14 |
| Working Capital | 15.51M |
Cash Flow
In the last 12 months, operating cash flow was $57.17 million and capital expenditures -$53.75 million, giving a free cash flow of $3.42 million.
| Operating Cash Flow | 57.17M |
| Capital Expenditures | -53.75M |
| Free Cash Flow | 3.42M |
| FCF Per Share | $0.09 |
Margins
Gross margin is 45.50%, with operating and profit margins of 4.71% and 1.43%.
| Gross Margin | 45.50% |
| Operating Margin | 4.71% |
| Pretax Margin | 4.15% |
| Profit Margin | 1.43% |
| EBITDA Margin | 13.22% |
| EBIT Margin | 5.82% |
| FCF Margin | 0.52% |
Dividends & Yields
UTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.81% |
| Shareholder Yield | -8.81% |
| Earnings Yield | 1.18% |
| FCF Yield | 0.43% |
Analyst Forecast
The average price target for UTI is $15.20, which is 1.47% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.20 |
| Price Target Difference | 1.47% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
UTI has an Altman Z-Score of 2.06 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.06 |
| Piotroski F-Score | 6 |